- Home
- AGL
as 03-28-2025 4:00pm EST
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | AUSTIN |
| Market Cap: | 1.4B | IPO Year: | 2021 |
| Target Price: | $3.85 | AVG Volume (30 days): | 5.8M |
| Analyst Decision: | Hold | Number of Analysts: | 18 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.63 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.50 - $7.73 | Next Earning Date: | 05-06-2025 |
| Revenue: | $6,060,530,000 | Revenue Growth: | 40.41% |
| Revenue Growth (this year): | 2.12% | Revenue Growth (next year): | 13.99% |
Latest agilon health inc. News
AGL Breaking Stock News: Dive into AGL Ticker-Specific Updates for Smart Investing
Insider Monkey
5 days ago
Agilon Health Inc. (NYSE:AGL): Amazing Performance So Far In 2025
Business Wire
6 days ago
agilon health Sets Date to Report First Quarter 2025 Financial Results
Zacks
11 days ago
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?
Benzinga
13 days ago
Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals
StockStory
18 days ago
Healthcare Providers & Services Stocks Q4 In Review: The Ensign Group (NASDAQ:ENSG) Vs Peers
StockStory
18 days ago
Outpatient & Specialty Care Stocks Q4 Results: Benchmarking U.S. Physical Therapy (NYSE:USPH)
StockStory
19 days ago
3 Growth Stocks with Explosive Upside
Simply Wall St.
25 days ago
Undervalued Small Caps With Insider Buying In The Region
Compare AGL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AGL agilon health inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.